 Notes from the East
Woods musings on opportunities in the life science
marketplace
June 2009
|
|
|
|
Greetings!
|
Flying an ultralight aircraft may not be the best approach to running a business Please have a read and feel free to let me know what you think. Thanks.
Regards,
Paul Danis Founder and Principal
ps. if you missed some of our earlier Notes, you can see them here.
|
|
|
|
|
|
Flying an Ultralight Company
|
I was enjoying a little peace and quite in the East Woods
last weekend when the stillness was dashed by the sound of a chainsaw above my
head. I looked up and saw what looked
like an outsized kite with a motor and a person. This so-called ultralight aircraft was a
funny looking, albeit functional vehicle, and it reminded me of how some
companies are running their businesses these days.
They operate with only the bare essentials to keep the
company functional, eliminating "non-essential" activities. They have few long-term investments in new
products, no employee development activities, and just enough gas to keep it
out of the trees. While a great survival
tactic, it has big-time downsides that need to be considered.
-
Running light can lead to improved mobility and agility
since the organization is smaller.
However, it may be very hard to capitalize on new opportunities with the
reduced resources available.
-
Like in a smaller aircraft, the ride is pretty bumpy as
small changes in the environment (marketplace) can buffet the company around. A new competitor here or there, loss of a
couple key customers, and instability can set in.
-
The risks of ultralights are obvious since you don't need a
pilot's license to fly, and the accident rate is higher than conventional
aircraft. Similarly running the company
on the edge of stability will cause some to fall into a tailspin.
-
Contrary to what you are led to believe, not everyone is
flying by the seat of their pants. If
you consider pharma and biotech, they are spending around $65B this year on
R&D. If you add in the government
funding, well over $100B this year will be spent on discovering new biology,
developing new therapeutics and diagnostics, and furthering our understanding
of disease. Also in Q1 of this year,
$1.4B was invested in over 80 early stage life science companies.
So while the view is quite exciting as you skim over the
treetops with your ultralight company, take heed of the risks and missed
opportunities. There are still a number
of your comrades that are flying at a safe altitude and will surely capitalize
on the opportunities just over the horizon.
|
Life Science Market Update
|
|
Index
|
May Value
|
Change YTD
|
Yearly High
|
Yearly Low
|
|
EC BioTools
|
515
|
16%
|
515
|
411
|
|
EC BigPharma
|
700
|
-6%
|
709
|
617
|
|
EC Biotech
|
455
|
-7%
|
487
|
431
|
All life science indices followed the general market trends
and were up over last month with Pharma posting the largest gains, up 8% from
April's value. The tools sector was
quite mixed with Sigma and Thermo up nearly 10 % over April, whil Dionex was
down 11%. All members of the pharma
index were up, while in biotech, advances lead declines 4 to 1.
---------------------
Many of the life science
indices currently available are a mixture of various types of companies. In
order to better assess the situation in the different segments, Eastwoods
Consulting has created these price-weighted indices for the sectors of large
pharmaceutical companies, biotech companies, and life science research tools
companies.
-
EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR,
CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL,
TMO, VARI, WAT
-
EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, MRK, ABT,
LLY, AZN, WYE, BMY, NVO, BAX, TEVA, SGP, ROG.VX
-
EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD,
BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, MEDX, THRX, HGSI, SGMO, NKTR
-
Prices are
taken at the close of each month.
|
|
| About Eastwoods Consulting
|
Eastwoods Consulting helps companies connect their technologies and products with the life science marketplace. By focusing on the most valuable opportunities, efficiency is increased, and profits grow.
|
Copyright © 2009, Eastwoods Consulting. This
publication may be freely redistributed in full or in part as long as full
attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|